262 filings
8-K
NBIX
Neurocrine Biosciences, Inc.
7 Feb 24
Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024
7:00am
8-K
NBIX
Neurocrine Biosciences, Inc.
13 Nov 23
Other Events
7:01am
8-K
NBIX
Neurocrine Biosciences, Inc.
9 Nov 23
Other Events
5:03pm
8-K
NBIX
Neurocrine Biosciences, Inc.
31 Oct 23
Neurocrine Biosciences Reports Third Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance
7:01am
8-K
NBIX
Neurocrine Biosciences, Inc.
6 Oct 23
Other Events
9:00am
8-K
p182ibqpq0b nr
5 Oct 23
Other Events
7:02am
8-K
ugx5tsbig8pe9bp4 opp
12 Sep 23
Other Events
7:31am
8-K
cfdz80wcuh9o2cyfhd8
1 Aug 23
Neurocrine Biosciences Reports Second Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance
7:02am
8-K
q7udxs
13 Jul 23
Departure of Directors or Certain Officers
4:05pm
8-K
sz7jg5c
11 Jul 23
Departure of Directors or Certain Officers
7:04pm
8-K
6shq kzblqtdbpyh
19 May 23
Departure of Directors or Certain Officers
5:21pm
8-K
p9vrlv
3 May 23
Neurocrine Biosciences Reports First Quarter 2023 Financial Results
7:32am
8-K
ue5vk1kd1lftg2u
28 Mar 23
Other Events
8:44pm
8-K
rt8gxz qw
23 Feb 23
Other Events
7:14pm
8-K
yqaxol90
10 Feb 23
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
y1d69brlmi48jy
6 Feb 23
Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2022 Financial Results
7:32am
8-K
34s2dxrx
9 Jan 23
Entry into a Material Definitive Agreement
7:04am
8-K
mwh80q cr
1 Nov 22
Neurocrine Biosciences Reports Third Quarter 2022 Financial Results
7:31am
8-K
c1cw52
30 Aug 22
Regulation FD Disclosure
8:01am
8-K
1rzr daz0h
4 Aug 22
Neurocrine Biosciences Reports Second Quarter 2022 Financial Results
4:05pm